Omega-3 fatty acids are one of the most important nutrients for brain health. DHA, the type found primarily in fish and algae, is a major structural component of brain cell membranes and plays a direct role in how neurons communicate. Your brain depends on it from fetal development through old age, and low levels are linked to problems ranging from poor attention to increased dementia risk.
Why Your Brain Needs DHA
Of the three main omega-3 fatty acids (ALA, EPA, and DHA), DHA is the one your brain actually builds itself from. It integrates into the membranes of neurons, keeping them fluid and flexible. That flexibility matters because it allows the protein channels embedded in those membranes to open, close, and function properly. When omega-3 levels drop too low, membranes stiffen, and those channels come under physical stress that can impair their function.
The downstream effects of low DHA are striking. A deficiency reduces the density of signal-carrying vesicles in the hippocampus (your brain’s memory center) by 30%, cuts glucose uptake into neurons by 30%, and slashes stimulated dopamine release by 90%. Serotonin signaling also drops. These are the same chemical messengers involved in mood, motivation, focus, and memory, which helps explain why omega-3 status shows up in research on such a wide range of brain conditions.
DHA also serves as the raw material for specialized molecules called resolvins and protectins. When inflammation flares in the brain, these compounds actively shut it down: they shorten the lifespan of inflammatory cells, promote cleanup of damaged tissue, and protect neurons and supporting glial cells. One of these molecules, neuroprotectin D1, has been specifically studied for its role in resolving inflammation after brain stroke.
Brain Development in Infants
The brain’s need for DHA is highest during fetal development and early childhood, when synapses are forming rapidly. Synapse formation itself depends on DHA accumulation in the brain, which means a mother’s intake during pregnancy directly shapes this process.
In a randomized trial comparing prenatal DHA supplementation to placebo, infants whose mothers took DHA maintained high levels of sustained attention across the entire first year of life. In the placebo group, sustained attention declined over the same period. That specific pattern of maintained attention has been separately linked to higher vocabulary and intelligence scores at age four. The supplemented infants were also significantly less fussy: at six months, about 5% of the DHA group was too fussy to complete testing, compared to 24% of the placebo group.
Several international health bodies recommend that pregnant women consume at least 250 to 300 mg per day of combined EPA and DHA, with an additional 100 to 200 mg of DHA on top of that. For pregnant women with low DHA intake (under 150 mg per day), clinical guidelines suggest 600 to 1,000 mg per day starting in the second trimester.
Effects on Focus and ADHD
Children and young people with ADHD tend to have lower blood levels of omega-3s, and supplementation trials have shown measurable benefits. Across 13 studies reporting favorable outcomes, improvements appeared in hyperactivity, impulsivity, attention, visual learning, word reading, and working memory. In one analysis, increases in blood levels of EPA and DHA were directly associated with better spelling, improved attention, and reduced oppositional behavior, with statistically significant improvements across multiple ADHD symptom scales.
These effects are modest compared to stimulant medications, but they suggest omega-3s play a supporting role in the neurochemistry of attention. Given that omega-3 deficiency impairs dopamine signaling (the same system targeted by ADHD medications), the connection makes biological sense.
Depression and Mood
EPA, the other major marine omega-3, appears to be the more relevant form for mood disorders. In a 12-week randomized trial of adults with major depressive disorder, those taking 4 grams per day of EPA had a 64% response rate, compared to 40% for placebo. That translated to a medium effect size. Interestingly, lower doses of 1 or 2 grams per day did not outperform placebo in that study, suggesting that for depression with significant inflammation, higher doses may be necessary.
The anti-inflammatory properties of omega-3s likely play a role here. The trial specifically enrolled people with elevated markers of inflammation, and EPA’s ability to reduce inflammatory signaling in the brain may partly explain why it helps in this subgroup. This doesn’t mean omega-3s work as a standalone treatment for everyone with depression, but for people whose depression involves a strong inflammatory component, EPA supplementation at adequate doses shows real promise.
Protection Against Cognitive Decline
Higher omega-3 blood levels are associated with a lower risk of dementia. A large study examining early-onset dementia found that people in the top fifth of blood omega-3 levels had a 40% lower risk compared to those in the bottom fifth. This association held for both DHA and non-DHA omega-3s, and the relationship was consistent when omega-3 was analyzed as a continuous variable, meaning that higher levels tracked with progressively lower risk.
The mechanisms likely overlap with what’s already described: better membrane function, healthier neurotransmitter signaling, reduced neuroinflammation, and maintained glucose uptake in neurons. None of this guarantees prevention, but it does suggest that long-term omega-3 intake is one of the more evidence-supported dietary strategies for protecting brain function as you age.
Best Food Sources of Omega-3
The richest sources of brain-ready EPA and DHA are fatty fish. A 3-ounce serving of salmon provides about 4.5 grams of combined EPA and DHA. Other strong options include mackerel (about 2.5 grams per fillet), herring (1.5 grams per 3 ounces), and trout (0.5 grams per 3 ounces). Even light canned tuna provides around 170 mg per 3-ounce serving. Two to three servings of fatty fish per week will comfortably meet most adults’ needs.
Plant sources like flaxseed, chia seeds, and walnuts contain ALA, a precursor that your body can convert into EPA and DHA, but the conversion rate is poor. In men, only about 8% of ALA converts to EPA and less than 4% to DHA. Women convert somewhat more efficiently (roughly 21% to EPA, 9% to DHA), likely due to the influence of estrogen on the conversion enzymes. A tablespoon of flaxseed has 2.35 grams of ALA, and a cup of walnuts has about 3.3 grams, but after conversion losses, very little of that becomes the DHA your brain needs.
For people who don’t eat fish, algal oil is the best alternative. A tablespoon provides around 500 mg of DHA, sourced directly from the same microalgae that fish get their omega-3s from. This bypasses the conversion problem entirely.
Safety at Standard and High Doses
At typical supplemental doses, omega-3s have an excellent safety profile. A systematic review and meta-analysis of randomized trials found no increase in bleeding risk among people taking omega-3 supplements compared to placebo. Rates of hemorrhagic stroke, intracranial bleeding, and gastrointestinal bleeding were all similar between groups. Background use of blood-thinning medications did not change this finding.
The one exception involves high-dose purified EPA (the kind used in prescription formulations at 4 grams per day). At that level, there was a 50% relative increase in bleeding risk, but the absolute increase was only 0.6%, which researchers described as clinically very modest. For the vast majority of people taking standard fish oil or eating fish regularly, bleeding is not a meaningful concern.